Nagaoka Red Cross Hospital /ID# 214140

Nagaoka-shi, Niigata 940-2085

0 studies enrolling now · 1 studies all time

What they study most

Dermatitis

Studies at this site

• A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis — Completed